Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer
暂无分享,去创建一个
N. Sato | N. Masumori | H. Kitamura | Toshiaki Tanaka | Y. Hirohashi | T. Torigoe | T. Tsukamoto | A. Takahashi | I. Honma | Eiji Sato